First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System

Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sondergaard, Lars, Møller, Jacob Eifer, De Backer, Ole, Møller-Sørensen, Peter Hasse, Cheng, Yanping, Rossing, Kasper, Smerup, Morten, Quadri, Arshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157149/
https://www.ncbi.nlm.nih.gov/pubmed/37152699
http://dx.doi.org/10.1016/j.jaccas.2023.101841
Descripción
Sumario:Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.)

Ejemplares similares